Navigation Links
Inhibition of morphine tolerance by spinal melanocortin receptor blockade

Recent research suggests that the melanocortin system is an important component influencing the changes in the spinal neuronal plasticity observed after chronic morphine administration//.

The chronic use of morphine is accompanied by the development of morphine tolerance, which is one of the major problems associated with opiate treatment. Possible modulation of opioid effects by melanocortin receptor ligands has been recently demonstrated.

Researchers from Poland, writing in the October issue of the journal Pain, investigated the influence of repeated intrathecal injection of a melanocortin receptor antagonist on the development of morphine tolerance as measured by tail-flick test. It was also examined whether a single administration of the antagonist could counteract the loss of analgesic potency of morphine in morphine tolerant rats. The authors examined also the influence of chronic morphine administration on ì-opioid receptor (MOR) and melanocortin 4 receptor (MC4-R) mRNAs in the rat spinal cord and dorsal root ganglia (DRG) during morphine tolerance.

Morphine treatment over 8 days induced tolerance as reflected by a significant reduction of withdrawal latency from 181 to 25% above baseline in the tail-flick test. Repeated co-administration of morphine and melanocortin receptor antagonist, significantly prevented the development of morphine tolerance.

A single administration of an MC4-R antagonist restored morphine analgesic potency in morphine tolerant rats. Using RT-PCR they demonstrated no changes in the spinal cord but there was a decrease in MOR and increase in MC4-R gene expression in the DRG of rats tolerant to morphine. These results suggest that MC4-R may be involved in the mechanisms of opioid tolerance and antagonists of this receptor may be a possible new target in the search for strategies preventing the development of opioid tolerance. The authors propose that besides other systems, the melanocortin s ystem may also be involved in the changes in spinal neuronal plasticity. The specific MC4-R antagonists would be promising compounds to alleviate the side effects of long-term morphine treatment. Their ability to restore morphine analgesia may have clinical benefits.

The melanocortin receptor antagonist tested may widen the options of the use of opioids for treatment of chronic pain by reducing the need for opioid dose escalation, which is often associated with unwanted side effects and by attenuating the development of analgesic tolerance and hyperalgesia following chronic use of morphine.
'"/>




Related medicine news :

1. Anonymity Helps In Overcoming Inhibitions During Online Counseling
2. Inhibition of Colorectal tumor growth by Grape seed extract
3. Gluten Intolerance Quadruples Susceptibility to Tuberculosis
4. Brain development in teens curbed by alcohol tolerance
5. Exercise Intolerance In Heart Failure Patients Is Explored By Researchers
6. Inflammatory Myopathy may Indicate Intolerance to Gluten
7. Useful device makes spinal surgery safer
8. New hope for spinal cord injury victims
9. Acrolein may be the key to halting spinal cord damage
10. Cervical spinal injury patients may have more damage left undetected
11. New spinal surgery technique developed by UCSF Surgeon
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure today ... for and donate to Give To Cure’s campaign that is crowdfunding clinical trials to ... make and share payments through a smart device. In 2015 alone, Venmo processed $7.5 ...
(Date:2/5/2016)... ... , ... Dr. Justin Scott and Dr. Lydia Muccioli of Pure Dental ... individuals in need. The event is scheduled to take place on February 27, 2016 ... provide dental care to community members in need. Each patient will be given the ...
(Date:2/5/2016)... , ... February 05, 2016 , ... In sleep, when ... as a dream. A hallmark feature of patients with eating disorders is significant self-criticism, ... eating disorder behaviors and obsessions are regarded as maladaptive means for coping with this ...
(Date:2/5/2016)... ... , ... Calls Blacklist has just been updated by mobile app developer Vlad ... has fixed known bugs within the app. Calls Blacklist allows its users to only ... any of their device’s battery power or memory. It provides a powerful call blocker ...
(Date:2/5/2016)... ... 05, 2016 , ... When one is tired of trying to cram belongings into spare space ... to rent a storage unit, but before hastily spending money on a unit, take these ... more space. But what one is often not told when utilizing these services are some ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... 2016  Syneron Medical Ltd. (NASDAQ: ELOS ... today that William Griffing , Chief Executive ... to participate in the Leerink Partners 5 th ... 2016 in New York City ... meet with the Mr. Griffing and will include ...
(Date:2/5/2016)... , Feb. 5, 2016  Patients in Alabama ... focused ultrasound (HIFU) therapy no longer have to travel out ... its partnership with Urology Centers of Alabama to ... FDA-cleared procedure for qualifying patients. Alabama ... in the treatment of prostate cancer using many different modalities. ...
(Date:2/5/2016)... -- Aethlon Medical, Inc. (Nasdaq: AEMD ), today announced ... presenting at Source Capital Group,s 2016 Disruptive Growth & Healthcare ... 2:15 p.m. ET on Wednesday, February 10, 2016.  Mr. Joyce ... at 3:15 p.m. ET. http://www.aethlonmedical.com .  The webcast ... conclusion of the live event. The panel discussion will not ...
Breaking Medicine Technology: